Medistim ASA
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in… Read more
Market Cap & Net Worth: Medistim ASA (MEDI)
Medistim ASA (OL:MEDI) has a market capitalization of $331.98 Million (Nkr3.78 Billion) as of March 18, 2026. Listed on the OL stock exchange, this Norway-based company holds position #14282 globally and #43 in its home market, demonstrating a -2.36% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medistim ASA's stock price Nkr207.00 by its total outstanding shares 18273093 (18.27 Million).
Medistim ASA Market Cap History: 2015 to 2026
Medistim ASA's market capitalization history from 2015 to 2026. Data shows growth from $71.79 Million to $331.98 Million (17.13% CAGR).
Medistim ASA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medistim ASA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.43x
Medistim ASA's market cap is 0.43 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
2.31x
Medistim ASA's market cap is 2.31 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $71.79 Million | $249.97 Million | $40.42 Million | 0.29x | 1.78x |
| 2016 | $101.60 Million | $262.67 Million | $39.10 Million | 0.39x | 2.60x |
| 2017 | $102.08 Million | $296.05 Million | $47.57 Million | 0.34x | 2.15x |
| 2018 | $103.14 Million | $323.01 Million | $57.05 Million | 0.32x | 1.81x |
| 2019 | $284.39 Million | $356.91 Million | $70.31 Million | 0.80x | 4.05x |
| 2020 | $374.91 Million | $356.21 Million | $69.39 Million | 1.05x | 5.40x |
| 2021 | $557.57 Million | $417.82 Million | $90.90 Million | 1.33x | 6.13x |
| 2022 | $355.62 Million | $491.94 Million | $113.97 Million | 0.72x | 3.12x |
| 2023 | $334.72 Million | $526.36 Million | $103.82 Million | 0.64x | 3.22x |
| 2024 | $239.76 Million | $562.60 Million | $103.83 Million | 0.43x | 2.31x |
Competitor Companies of MEDI by Market Capitalization
Companies near Medistim ASA in the global market cap rankings as of March 18, 2026.
Key companies related to Medistim ASA by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Medistim ASA Historical Marketcap From 2015 to 2026
Between 2015 and today, Medistim ASA's market cap moved from $71.79 Million to $ 331.98 Million, with a yearly change of 17.13%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Nkr331.98 Million | -20.08% |
| 2025 | Nkr415.37 Million | +73.24% |
| 2024 | Nkr239.76 Million | -28.37% |
| 2023 | Nkr334.72 Million | -5.88% |
| 2022 | Nkr355.62 Million | -36.22% |
| 2021 | Nkr557.57 Million | +48.72% |
| 2020 | Nkr374.91 Million | +31.83% |
| 2019 | Nkr284.39 Million | +175.72% |
| 2018 | Nkr103.14 Million | +1.05% |
| 2017 | Nkr102.08 Million | +0.47% |
| 2016 | Nkr101.60 Million | +41.53% |
| 2015 | Nkr71.79 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Medistim ASA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $331.98 Million USD |
| MoneyControl | $331.98 Million USD |
| MarketWatch | $331.98 Million USD |
| marketcap.company | $331.98 Million USD |
| Reuters | $331.98 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.